A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis

Clinical trial NCT02791516 · COMPLETED

Trial details

NCT number: NCT02791516
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2017-01-16
Primary completion: 2018-02-12
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.